Comparative clinical landscaping and competitive analyses
NCCN Guidelines and Compendium Positioning Strategy
NCCN Submission Letters (e.g., on-label, off-label)
Other CMS-recognized compendia and pathways
Clinical data modeling and forecasting regarding payer response and coverage
Stakeholder messaging and value messaging strategy
Compendia strategy and submissions
Navigating coverage policy and utilization management
Pipeline and pre-launch strategy, direction, and positioning for oncology and specialty products
Economic/Financial Policy and Strategy
Payer-based forecast scenarios and revenue projections
Alternative Payment Models (APMs) portfolio impact modeling
Models and scenario analyses for financial impact of policy (e.g., value-based reimbursement)
Health policy impact assessment and strategy
Impact of Oncology Value Metrics frameworks
Strategic health economics tools (e.g., "Retail vs. Real Price" and alternatives to the QALY)
Forecasting, Modeling, and Value Impact Analysis
Price/value justification and policy presentation
Understanding impact of utilization management tools (precert, step therapy, tiering) on specific products and forecasting impact
Payment method changes and impact on sales (340b, bundled payments)
Modeling impact of policy changes on specific products, therapeutic areas, or portfolio-wide (including key pipeline agents)
Acquisition/In-Licensing Valuation and Strategy
Assest evaluation and due diligence through competitive clinical and economic analysis
Financial modeling with revenue projections
Valuation of brand product end of lifecycle in face of generic and biosimilar entry and competition
Advisory Boards and Market Research Insights
Advisory Boards, Summits, Focus Groups, and interview series with national thought leaders from the payer, provider, patient, and policy spheres
Data, Evidence, and Competitive Positioning
Competitive and Comparative decision-making intelligence
Understanding and monitoring data and product positioning in EMRs/EHRs, order sets, and decision-assist tools
Data analysis and strategy for indication expansion
Long term data collection and analysis in Phase IV to enhance positioning throughout product life-cycle
Strategy for longitudinal databases and big data
Training, Education, and Publications
Comprehensive ongoing corporate (e.g., national sales force) training and education
Cross-functional alignment training and education on policy, payer strategy, and market access
Full-day workshops on guideline (e.g., NCCN), compendia, and pathways processes, positioning, and implications
Strategic publication planning
Key Opinion Organization (KOO)/Key Opinion Leader (KOL) relationship mapping, descriptions, internal assignments, and stakeholder targeted data information packets
Prospective outlook on strategic planning opportunities for guidelines and compendia
SERVICES AND CAPABILITIES
